Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.
5. FDA’s expansion of the use of Lynparza for breast cancer with specific inhibited genetic mutation is on our list at number five.
FDA expands use of Lynparza to include breast cancer with specific inherited genetic mutation
4. Fourth position for the week is the news that Systech has expanded its European presence to help with EU FMD preparations.
Systech expands European presence helping preparations for the EU FMDh
3. 3P innovation’s plans to expand UK operations makes it into third place.
3P innovation reveals plans to expand UK operations
2. Runner up in this week’s Top Five goes to Desktop Genetics’ announcement that it has received the worldwide licensing rights to CRISPR efficiency web tool.
Biotech receives worldwide licensing rights to web tool for CRISPR efficiency, TIDE
1. Number one this week is the news that the BIA has been granted permission to intervene in a Supreme Court case.